News

Displaying 1 - 20 of 29

European Commission proposes to control two harmful new psychoactive substances

12.03.2021

Today, the European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which have been raising health concerns in Europe (1). The proposal to...

EMCDDA preparedness and response to a fast-moving drugs problem

30.04.2020

Revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live, have called for constant reflection, innovation and agility to keep pace with new developments and rethink existing routines. This is why the EMCDDA has adopted a multi-indicator approach...

New legislation, bringing faster response to new drugs, applies from today

23.11.2018

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) will be significantly strengthened, thanks to new legislation applying from today (1). The legislation — applicable across Europe from 23 November 2018 — strengthens the...

Two new synthetic opioids to be placed under control across the EU

28.09.2018

Today, the European Union has decided to subject two new synthetic opioids to control measures across the 28 Member States. The implementing decision of the Council of the EU (1), based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure...

EMCDDA publishes latest insights into NPS in Europe

07.06.2018

In a new update from the EU Early Warning System (EWS) on new psychoactive substances (NPS) (1), the EMCDDA releases today its latest insights in this area entitled Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. This is the second update from the EU Early...

Two new synthetic cannabinoids to be placed under control across the EU

14.05.2018

Today the European Union has decided to subject two new synthetic cannabinoids to control measures across the 28 Member States (1). The implementing decisions of the Council of the EU (2), based on proposals by the European Commission, were adopted in the final stage of the three-step legal...

New legislation published today to bring faster response to new drugs

21.11.2017

Europe’s ability to rapidly respond to public health and security threats caused by new psychoactive substances (NPS) will be significantly strengthened, thanks to new legislation published today by the European Union (1). The legislation includes a stronger EU Early Warning System (EWS) and a...

Furanylfentanyl to be placed under control across the EU

15.11.2017

Today the European Union has decided to subject the new synthetic opioid furanylfentanyl to control measures throughout the EU (1). The implementing decision of the Council of the EU (2), based on an initial proposal by the European Commission, was adopted in the final stage of the three-step legal...

Acryloylfentanyl to be placed under control across the EU

29.09.2017

This week, the EU has reacted to serious concerns over the use of the synthetic opioid acryloylfentanyl by deciding to subject it to ‘control measures’ throughout the Union (1). The implementing decision of the Council of the EU (2) was adopted in the final stage of the three-step legal procedure...

EMCDDA highlights growing threats posed by new and established substances

06.06.2017

Rising overdose deaths, the continued availability of new psychoactive substances and the growing health threat of highly potent synthetic opioids are among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2017: Trends and Developments in Brussels...

MDMB-CHMICA to be placed under control across the EU

27.02.2017

Today, the EU reacted to serious concerns over the use of the synthetic cannabinoid MDMB-CHMICA by deciding to subject it to ‘control measures’ throughout the Union (1). The implementing decision of the Council of the EU (2) was adopted in the final stage of the three-step legal procedure designed...

Council adopts its position on the reform of the new psychoactive substances legislation

09.12.2016

On 8 December, the Council adopted its position on a package reforming the legislation on new psychoactive substances (NPS) as well as improving the information exchange, early warning system and risk assessment procedure at EU level. The Council is now ready to start negotiations with the...

New psychoactive substances: Commission proposes new ban and strengthens the EU's Early Warning System and risk assessment

31.08.2016

Today, the European Commission has proposed to subject the new psychoactive substance MDMB-CHMICA (sometimes referred to as ‘Black Mamba’) to control measures across the European Union.  According to the risk assessment report provided by EMCDDA, the acute toxicity of MDMB-CHMICA can cause severe...

4,4'-DMAR and MT-45 to be placed under control across the EU

20.10.2015

Europe has responded to rising concerns over the use of two new drugs by subjecting them to ‘control measures and criminal penalties’ throughout the Union. The implementing decision of the Council of the EU (1), published in the Official Journal of the European Union today, was adopted in the final...

Annual meeting of the Reitox Early Warning System network

09.06.2015

The latest developments in monitoring and responding to new psychoactive substances (NPS/'new drugs') were discussed at the 15th annual meeting of the Reitox Early Warning System (EWS) network, held in Lisbon from 8–9 June. The meeting opened with a summary of the findings of the 2014 EMCDDA–...

EMCDDA presents latest update on ‘new drugs’ from EU Early Warning System

09.03.2015

Among the public health concerns highlighted in the report are new synthetic opioids — often highly potent and sold as heroin to unsuspecting users — posing a high risk of overdose. Three of the five opioids reported in 2014 were fentanyls, a family of drugs that have caused hundreds of deaths in...

Four new drugs to be placed under control

25.09.2014

Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe. With today's decision, the substances MDPV, methoxetamine, AH-7921, and 25I-NBOMe will be subject to control measures and criminal penalties...

EMCDDA welcomes European Commission call for stronger EU action on new drugs

17.09.2013

The EU drugs agency (EMCDDA) welcomes the European Commission's proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’)(1). The proposal follows an unprecedented rise in the number of new drugs detected in Europe in recent years and a Commission review of the EU’...

Over 100 specialists from across the globe to review international developments in new drugs field

24.06.2013

Leading European and international specialists will meet in Lisbon from 27–28 June to take stock of the global new drugs phenomenon. The Third international multidisciplinary forum on new drugs, organised by the EU drugs agency (EMCDDA), in cooperation with Europol, will gather over 100...

New drugs cause fundamental shift in Europe’s drug market

28.05.2013

The number, type and availability of new drugs in Europe continued to increase in 2012, according to a report released today by the EMCDDA and Europol (1). Driven by globalisation, technological advancement and the Internet, an open market for new drugs has now developed which presents significant...
Loading